Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.–10. rezultāts no 100.
333. lappuse
... immediate con- tainers of the diluent collected at regu- lar intervals throughout each filling operation , except that if the diluent is sterilized after filling into containers , the representative sample shall consist of 20 immediate ...
... immediate con- tainers of the diluent collected at regu- lar intervals throughout each filling operation , except that if the diluent is sterilized after filling into containers , the representative sample shall consist of 20 immediate ...
335. lappuse
... immediate container of penicillin when it is in- cluded in the packaged combination penicillin with aluminum hydroxide gel or penicillin with a vasoconstrictor , or to any immediate container of baci- tracin when it is included in the ...
... immediate container of penicillin when it is in- cluded in the packaged combination penicillin with aluminum hydroxide gel or penicillin with a vasoconstrictor , or to any immediate container of baci- tracin when it is included in the ...
339. lappuse
... immediate containers shall be tight containers as defined by the U.S.P. , except that if the antibiotic drug is dispensed as an ointment or cream , the immediate con- tainers shall be well - closed containers as defined by the U.S.P. If ...
... immediate containers shall be tight containers as defined by the U.S.P. , except that if the antibiotic drug is dispensed as an ointment or cream , the immediate con- tainers shall be well - closed containers as defined by the U.S.P. If ...
340. lappuse
... immediate container , the following : or ( 1 ) The number of units micrograms of activity per milligram or per gram , and the number of grams or kilograms in the immediate con- tainer . ( 2 ) The batch mark . ( 3 ) The statement ...
... immediate container , the following : or ( 1 ) The number of units micrograms of activity per milligram or per gram , and the number of grams or kilograms in the immediate con- tainer . ( 2 ) The batch mark . ( 3 ) The statement ...
349. lappuse
... immediate con- tainers that are tight containers as de- fined by the U.S.P. Each such con- tainer shall contain not more than 1 gram . ( c ) Each package bears on the label or labeling of its outside wrapper or container and the immediate ...
... immediate con- tainers that are tight containers as de- fined by the U.S.P. Each such con- tainer shall contain not more than 1 gram . ( c ) Each package bears on the label or labeling of its outside wrapper or container and the immediate ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning